Hyperactivity induced by prenatal nicotine exposure is associated with an increase in cortical nicotinic receptors

Pharmacology Biochemistry and Behavior

Volumn 58, Issue 1, 1997, Pages 141-146

  Tizabi, Yousef ^a   Popke, E Jon ^b   Rahman, Matthew A ^b   Nespor, Stephanie M ^b   Grunberg, Neil E ^b  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Cortex; Gender; Hyperactivity; Locomotor activity; Nicotine; Nicotinic receptors; Prenatal; Rat; Striatum

Indexed keywords

NICOTINE; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; FEMALE; HYPERACTIVITY; LOCOMOTION; MALE; NEWBORN; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RAT; RECEPTOR DENSITY; SEX DIFFERENCE;

ANIMALS; CEREBRAL CORTEX; FEMALE; HYPERKINESIS; KINETICS; MALE; NICOTINE; NICOTINIC AGONISTS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NICOTINIC;

ANIMALIA;

EID: 0030837536     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0091-3057(96)00461-3     Document Type: Article

References (50)

1. Arendash G. W., Sengstock G. J., Sanberg P. R., Kem W. R. Improved learning and memory in aged rats with chronic administration of the nicotinic receptor agonist GTS-21. Brain Res. 674:1995;252-259.
2. Benowitz N. L., Porchet H., Jacob P. III Nicotine dependence and tolerance in man. Pharmacokinetic and pharmacodynamic investigations Prog. Brain Res. 79:1989;279-287.
3. Bradford M. M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
4. Butler N. R., Goldstein H. Smoking in pregnancy and subsequent child development. Br. Med. J. 4:1973;573-574.
5. 3H](-)nicotine binding sites in fetal human brain. Brain Res. 475:1988;1-7.
6. Clarke P. B. S. Mapping of brain nicotinic receptors by autoradiographic techniques and the effect of experimental lesions. Prog. Brain Res. 79:1989;65-71.
7. 125I-alpha-bungarotoxin J. Neurosci. 5:1985;1307-1315.
8. Decker M. W., Brioni J. D., Bannon A. W., Arneric S. P. Diversity of neuronal nicotinic acetylcholine receptors. Lessons from behavior and implications for CNS therapeutics Life Sci. 56(8):1995;545-570.
9. Denson R., Anson J. L., McWatters M. A. Hyperkinesis and maternal smoking. Can. Psychiatr. Assoc. J. 20:1975;183-187.
10. Fergusson D. M., Horwood L. J., Lynskey M. T. Maternal smoking before and after pregnancy. Effects on behavioral outcomes in middle childhood Pediatrics. 92:1993;815-822.
11. Fung Y. K. Postnatal behavioral effects of maternal nicotine exposure in rats. J. Pharm. Pharmacol. 40:1988;870-872.
12. Fung Y. K. Postnatal effects of maternal nicotine exposure on the striatal dopaminergic system in rats. J. Pharm. Pharmacol. 41:1989;576-578.
13. Fung Y. K., Lau Y. S. Effects of prenatal nicotine exposure on rat striatal dopaminergic and nicotinic systems. Pharmacol. Biochem. Behav. 33:1989;1-6.
14. Grenhoff J., Sevensson T. H. Pharmacology of nicotine. Br. J. Addict. 84:1989;477-492.
15. 31]nicotine binding in the fetal brain. Int. J. Dev. Neurosci. 3:1985;567-571.
16. Kristjansson E. A., Fried P. A., Watkinson B. Maternal smoking affects children's vigilance performance. Drug Alcohol Depend. 24(2):1989;11-19.
17. Levin E. D. Nicotinic systems and cognitive function. Psychopharmacology. 108:1992;417-431.
18. Levin E. D., Briggs S. J., Channelle C. N. Prenatal nicotine exposure and cognitive performance in rats. Neurotoxicol. Teratol. 15(4):1993;251-260.
19. Lichtensteiger W., Ribary U., Schlumpf M., Odermatt B., Widmer R. Prenatal adverse effects of nicotine on the developing brain. Prog. Brain Res. 73:1988;137-157.
20. Luck W., Nau H., Hansen R., Steldinger R. Extent of nicotine and cotinine transfer to the human fetus, placenta and amniotic fluid of smoking mothers. Dev. Pharmacol. Ther. 8:1985;384-395.
21. Marks M. J., Grady S. R., Collins A. C. Downregulation of nicotinic receptor function after chronic nicotine infusion. J. Pharmacol. Exp. Ther. 266:1993;1268-1276.
22. Martin J. C., Martin D. C., Radow B., Sigman G. Growth, development and activity in rat offspring following maternal drug exposure. Exp. Aging Res. 2:1976;235-251.
23. McNerney M. E., Szeto H. H. Prenatal nicotine exposure evokes changes in the incidence and degree of fetal electrocortical activation. J. Pharmacol. Exp. Ther. 267:1993;1460-1469.
24. Munson P. J., Rodbard D. Ligand. A versatile computerized approach for characterization of ligand-binding systems Anal. Biochem. 107:1980;220-239.
25. Naeye R. L., Peters E. C. Mental development of children whose mothers smoked during pregnancy. Obstet. Gynecol. 64:1984;601-607.
26. Navarro H. A., Seidler F. J., Schwartz R. D., Baker F. E., Dobbins S. S., Slotkin T. A. Prenatal exposure to nicotine impairs nervous system development at a dose which does not affect viability or growth. Brain Res. Bull. 23:1989;187-192.
27. 3H]cytisine binding to nicotinic cholinergic receptors in brain. Mol. Pharmacol. 39(10):1991;9-12.
28. Peng X., Gerzanich V., Anand R., Whiting P. J., Lindstrom J. Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover. Mol. Pharmacol. 46:1994;523-530.
29. Peters D. A. V., Tang S. Sex-dependent biological changes following prenatal nicotine exposure in the rat. Pharmacol. Biochem. Behav. 17:1982;1077-1082.
30. Ribary U., Lichtensteiger W. Effects of acute and chronic prenatal nicotine treatment on central catecholamine systems of male and female rat fetuses and offspring. J. Pharmacol. Exp. Ther. 248:1989;786-792.
31. Richardson S. A., Tizabi Y. Hyperactivity in the offspring of nicotine-treated rats. Role of the mesolimbic and nigrostriatal dopaminergic pathways Pharmacol. Biochem. Behav. 47:1994;331-337.
32. Rosecrans J. A. The psychopharmacological basis of nicotine's differential effects on behavior. Individual subject variability in the rat Behav. Genet. 25:1995;187-196.
33. Rosecrans J. A., Karan L. D. Neurobehavioral mechanisms of nicotine action. Role in the initiation and maintenance of tobacco dependence J. Subst. Abuse Treat. 10:1993;161-170.
34. Sanderson E. M., Drasdo A. L., McCrea K., Wonnacott S. Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific. Brain Res. 617:1993;349-352.
35. Schlumpf M., Gahwiller M., Ribary U., Lichtensteiger W. A new device for monitoring early motor development. Prenatal nicotine-induced changes Pharmacol. Biochem. Behav. 30:1988;199-203.
36. Schwartz R. D., Kellar K. J. Nicotinic cholinergic receptor binding sites in the brain. Regulation in vivo Science. 228:1983;214-216.
37. Seidler F. J., Albright E. S., Lappi S. E., Slotkin T. A. In search of a mechanism for receptor-mediated neurobehavioral teratogenesis by nicotine. Catecholamine release by nicotine in immature rat brain regions Brain Res. Dev. Brain Res. 82(1-2):1994;1-8.
38. Seidler F. J., Levin E. D., Lappi S. E., Slotkin T. A. Fetal nicotine exposure ablates the ability of postnatal nicotine challenge to release norepinephrine from rat brain regions. Dev. Brain Res. 69:1992;288-291.
39. Sershen H., Reith M. E. A., Banay-Schwartz M., Lajtha A. Effects of prenatal administration of nicotine on amino acid pools, protein metabolism, and nicotine binding in the brain. Neurochem. Res. 7:1982;1515-1522.
40. Slotkin T. A., Lappi S. E., Seidler F. J. Impact of fetal nicotine exposure on development of rat brain regions. Critical sensitive periods or effects of withdrawal? Brain Res. Bull. 31:1993;319-328.
41. 3H]nicotine binding sites in brain regions of rats exposed to nicotine prenatally via maternal injections or infusions. J. Pharmacol. Exp. Ther. 242:1987;232-237.
42. Stolerman I. P. Behavioural pharmacology of nicotine. Multiple mechanisms Br. J. Addict. 86:1991;533-536.
43. Stough C., Mangan G., Bates T., Frank N., Kerkin B., Pellett O. Effects of nicotine on perceptual speed. Psychopharmacology. 119:1995;305-310.
44. Streissguth A. P., Martin D. C., Barr H. M., Sandman B. M., Kirchner G. L., Darby B. L. Intrauterine alcohol and nicotine exposure. Attention and reaction time in 4-year-old children Dev. Psychol. 20:1984;533-541.
45. US Department of Health Human Services The health consequences of smoking. Nicotine addiction, a report of the Surgeon General:1988;US Department of Health and Human Services, DHHS Publication No. (CDC) 88-8406. Washington, DC.
46. Van De Kamp J. L., Collins A. C. Prenatal nicotine alters nicotinic receptor development in the mouse brain. Pharmacol. Biochem. Behav. 47:1994;889-900.
47. Warburton D. M. Nicotine as a cognitive enhancer. Prog. Neuropsychopharmacol. Biol. Psychiatry. 16(2):1992;181-191.
48. West R., Grunberg N. E. Implication of tobacco use as an addiction. Br. J. Addict. 86:1991;485-488.
49. Wonnacott S. The paradox of nicotinic acetylcholine receptor up-regulation by nicotine. Trends Pharmacol. Sci. 11:1990;216-219.
50. Wonnacott S., Drasdo A., Sanderson E., Rowell P. Presynaptic nicotinic receptors and the modulation of transmitter release. Ciba Found. Symp. 152:1990;87-101.